Borderline personality disorder
- PMID: 34688371
- DOI: 10.1016/S0140-6736(21)00476-1
Borderline personality disorder
Abstract
Borderline personality disorder (BPD) is a mental disorder with a high burden on patients, family members, and health-care systems. The condition was previously regarded as untreatable, but progress in understanding and management has resulted in earlier diagnosis and better treatment outcomes. A coherent syndrome of BPD typically onsets during adolescence (after age 12 years). BPD is often preceded by or co-develops with symptoms of internalising disorders (depression and anxiety), externalising disorders (conduct problems, hyperactivity, and substance use), or both. BPD is associated with various poor outcomes, including low occupational and educational attainment, lack of long-term relationships, increased partner conflict, sexual risk-taking, low levels of social support, low life satisfaction, and increased service use. Psychotherapy is the main treatment for BPD; drug treatment is only indicated for comorbid conditions that require medication, or during a crisis if psychosocial interventions are insufficient. Awareness of BPD by non-specialists, as well as specialists, is key to appropriate early intervention.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests MB is a cognitive-behavioural therapist, trained in DBT and with a special international activity in DBT training and dissemination. JSW is a cognitive-behavioural therapist, trained in DBT. CaS is a clinical psychologist with training in cognitive-behaviour therapy and mentalisation-based therapy. KL is a cognitive-behavioural psychotherapist with a special interest in schema therapy. AKU is a cognitive-behavioural therapist trained in DBT. ChS is a cognitive-behavioural therapist and has a sporadic consultancy agreement with Boehringer Ingelheim.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
